Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015

This statistic shows the time from filing to approval for NDA/BLA filings for new drugs in the U.S., in the period from January 1, 2006 to December 31, 2015, by disease area. It was found that new drugs in neurology took the longest average time to be approved, with an average of two years.

Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2006 and 2015

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2016

Region

United States

Survey time period

January 1, 2006 to December 31, 2015

Supplementary notes

NDA - New Drug Application.
BLA - Biologic License Application.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.